Exhibit 10.3
AMENDMENT NO.1 TO LOAN AGREEMENT
AMENDMENT NO. 1 to LOAN AGREEMENT
entered into as of March 31, 2009 (this "Amendment") by and between
Pharmacyclics, Inc., a Delaware corporation having a principal
place of business at 995 E. Arques Avenue, Sunnyvale, CA 94085-4521
(the "Company"), and Robert W. Duggan & Associates (the
"Lender")
WHEREAS, on December 30, 2008,
the Lender agreed to provide a loan to the Company in the principal
amount of Five Million Dollars ($5,000,000) (the "Initial Loan")
pursuant to a loan agreement entered into as of December 30, 2008
by and between the Company and the Lender (the "Initial Loan
Agreement");
WHEREAS, the Lender has agreed to
provide an additional loan to the Company in the amount of One
Million Four Hundred Thousand Dollars ($1,400,000) as financing
pursuant to the terms hereof (the "Second Loan,", and together with
the Initial Loan, the "Loan");
WHEREAS, for purposes of inducing
the Lender to make the Loan, the Company has agreed to issue a
first amended and restated unsecured promissory note to the Lender,
all as more particularly described herein below;
WHEREAS, the Company and the
Lender wish to amend and modify the Initial Loan Agreement upon the
terms and conditions set forth herein.
NOW, THEREFORE, in consideration
of the premises, and the representations, warranties and agreements
hereinbelow stated, and for other good and valuable consideration,
receipt and sufficiency of which is hereby acknowledged, the
parties hereto agree as follows:
1.
Definitions . All capitalized terms herein shall have the
meanings ascribed to them in the Initial Loan Agreement, unless
otherwise defined herein.
2.
Modifications of Initial Loan Agreement . From and after the
date hereof, the Initial Loan Agreement is hereby modified and
amended as follows:
1.1
The Loan . As of December 30, 2008, the Lender made
the Initial Loan and as of March 31, 2009, the Lender made the
Second Loan. The Loan shall be evidenced by, and subject to the
terms set forth in, a first amended and restated promissory note
dated March 31, 2009 in the form attached hereto as Exhibit
A (the "Note") made by the Company in favor of the
Lender.
1.2
Interest . The Initial Loan shall bear interest of
1.36% from December 30, 2008 until March 31, 2009 and the Loan
shall bear interest as follows: (i) the rate of interest in effect
for such day as publicly announced from time to time by Citibank
N.A. as its "prime rate" (the "Prime Rate") from April 1, 2009
until December 31, 2009 and (ii) the Prime Rate plus 2% from
January 1, 2010 until the expiration of the Note. Interest shall be
paid annually.
4.
Full Force and Effect . All terms, conditions and covenants
contained in the Initial Loan Agreement shall remain in full force
and effect except as specifically amended herein. The Initial Loan
Agreement, as amended hereby is ratified and confirmed.
5.
No Oral Changes . This Amendment may not be changed,
modified, discharged or terminated nor any of its provisions waived
orally, but only by an agreement in writing signed by the party
against whom enforcement of any change, modification, discharge,
termination or waiver is sought. From and after the date hereof,
all references to the Loan Agreement in the Note shall mean the
Loan Agreement as modified pursuant to the terms of this
Amendment.
6.
Successors and Assigns . This Amendment shall bind the
Company and the successors and assigns of the Company and shall
bind and inure to the benefit of the Lender, and successors and
assigns of Lender and all subsequent holders of the
Note.
7.
Counterparts . This Amendment may be executed in several
counterparts, each of which shall constitute an original, and all
of which, when taken together, shall constitute but one
instrument.
2
IN WITNESS WHEREOF, the
undersigned have executed this First Amendment to Loan Agreement on
the date above first written.
IN WITNESS WHEREOF, the parties
have executed this Agreement as of the day and year first set forth
above.
|
PHARMACYCLICS, INC.
|
|
ROBERT W. DUGGAN &
ASSOCIATES
|
|
995 E. Arques Avenue
Sunnyvale, California 94085-4521
|
|
193
|